Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Communications Medicine
|
May 23, 2022
Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia
Michael Asger Andersen, Mia Klinten Grand, Christian Brieghel, et al.
British Journal of Cancer
|
August 22, 2024
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma
Esben Packness, Olafur Birgir Davidsson, Klaus Rostgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2020
Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study
Michael Asger Andersen, Carsten Utoft Niemann, Klaus Rostgaard, et al.
Cephalalgia : an International Journal of Headache
|
February 15, 2021
Twenty-five years of triptans - a nationwide population study
Olafur B Davidsson, Isa A Olofsson, Lisette Ja Kogelman, et al.
BMJ Open
|
March 6, 2019
Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
Mariam Hussein Hleuhel, Yasmin Ben-Dali, Caspar Da Cunha-Bang, et al.
Leukemia & Lymphoma
|
February 7, 2016
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death
Michael Asger Andersen, Fie Juhl Vojdeman, Mette Klarskov Andersen, et al.
Acta Haematologica
|
May 3, 2018
Myeloproliferative Neoplasms in Danish Twins
Michael Asger Andersen, Ole Weis Bjerrum, Ajenthen Ranjan, et al.
Hemasphere
|
July 17, 2025
Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer
Christian Brieghel, Thomas Lacoppidan, Esben Packness, et al.
Leukemia & Lymphoma
|
November 7, 2024
Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic review
Cathrine Korsholm, Cille Bülow, Mikkel Christensen, et al.
Infection
|
June 28, 2022
Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours
Ashley Roen, Cynthia Terrones, Wendy Bannister, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Communications Medicine
|
May 23, 2022
Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia
Michael Asger Andersen, Mia Klinten Grand, Christian Brieghel, et al.
British Journal of Cancer
|
August 22, 2024
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma
Esben Packness, Olafur Birgir Davidsson, Klaus Rostgaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2020
Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study
Michael Asger Andersen, Carsten Utoft Niemann, Klaus Rostgaard, et al.
Cephalalgia : an International Journal of Headache
|
February 15, 2021
Twenty-five years of triptans - a nationwide population study
Olafur B Davidsson, Isa A Olofsson, Lisette Ja Kogelman, et al.
BMJ Open
|
March 6, 2019
Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
Mariam Hussein Hleuhel, Yasmin Ben-Dali, Caspar Da Cunha-Bang, et al.
Leukemia & Lymphoma
|
February 7, 2016
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death
Michael Asger Andersen, Fie Juhl Vojdeman, Mette Klarskov Andersen, et al.
Acta Haematologica
|
May 3, 2018
Myeloproliferative Neoplasms in Danish Twins
Michael Asger Andersen, Ole Weis Bjerrum, Ajenthen Ranjan, et al.
Hemasphere
|
July 17, 2025
Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer
Christian Brieghel, Thomas Lacoppidan, Esben Packness, et al.
Leukemia & Lymphoma
|
November 7, 2024
Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic review
Cathrine Korsholm, Cille Bülow, Mikkel Christensen, et al.
Infection
|
June 28, 2022
Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours
Ashley Roen, Cynthia Terrones, Wendy Bannister, et al.
Page
of 3